PKU HealthCare Corp.,Ltd. (SHE:000788)

Market Cap	3.96B
Revenue (ttm)	2.07B
Net Income (ttm)	139.59M
Shares Out	595.99M
EPS (ttm)	0.23
PE Ratio	28.40
Forward PE	n/a
Dividend	0.06 (0.90%)
Ex-Dividend Date	Jun 17, 2025

Volume	18,252,000
Average Volume	24,304,822
Open	6.50
Previous Close	6.67
Day's Range	6.50 - 6.67
52-Week Range	4.91 - 7.48
Beta	0.32
RSI	62.32
Earnings Date	Aug 22, 2025

About PKU HealthCare Corp.,Ltd.

PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, psychoneurological, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 772
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000788

Financial Performance

In 2024, PKU HealthCare Corp.,Ltd.'s revenue was 2.06 billion, a decrease of -6.10% compared to the previous year's 2.19 billion. Earnings were 137.99 million, an increase of 211.10%.